Atlas FDA

DIAPHRAGMATIC PACEMAKER PHRENIC NERVE STIMULATOR

FDA premarket approval P860026/S004 · decided 1998-03-03

Approval details

PMA number
P860026
Supplement
S004
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
DIAPHRAGMATIC PACEMAKER PHRENIC NERVE STIMULATOR
Generic name
implanted diaphragmatic/phrenic nerve Stimulator
Applicant
Avery Biomedical Devices, Inc.
Date received
1993-08-10
Decision date
1998-03-03
Days to decision
1666 days
Decision code
APPR
Product code
GZE
Advisory committee
Anesthesiology
Expedited review
No
Location
Commack, NY
Statement
Approval for bilateral stimulus output redundancy, external breathing rate control, antenna indicators which verify stimulus output and antenna integrity, concealed factory controls, additional covering to the battery connector, and design improvements to existing architecture that do no increase stimulus parameters above what was approved on January 5, 1987. The device, as modified, will be marketed under the trade name mark IV and is indicated for persons who require chronic ventilatory suppor

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.